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The utility of the VecTest antigen-capture assay to
detect West Nile virus (WNV) in field-collected dead corvids
was evaluated in Manitoba and Ontario, Canada, in 2001
and 2002. Swabs were taken from the oropharynx, cloaca,
or both of 109 American Crows, 31 Blue Jays, 6 Common
Ravens, and 4 Black-billed Magpies from Manitoba, and
255 American Crows and 28 Blue Jays from Ontario. The
sensitivity and specificity of the antigen-capture assay were
greatest for samples from American Crows; oropharyngeal
swabs were more sensitive than cloacal swabs, and inter-
laboratory variation in the results was minimal. The sensi-
tivity and specificity of the VecTest using oropharyngeal
swabs from crows were 83.9% and 93.6%, respectively, for
Manitoba samples and 83.3% and 95.8%, respectively, for
Ontario birds. The VecTest antigen-capture assay on
oropharyngeal secretions from crows is a reliable and rapid
diagnostic test that appears suitable for incorporation into a
WNV surveillance program. 
S
ince 2000, surveillance for West Nile virus (WNV) in
dead corvids has been the cornerstone of the early
warning system for this virus in the Canadian public
health system. During 2001 and 2002, WNV was detected
in avian tissues by using real-time TaqMan reverse tran-
scription–polymerase chain reaction (RT-PCR), as
described by Lanciotti et al. (1). Birds collected by local
or provincial authorities were sent to regional centers for
tissue collection. Tissue samples were shipped daily, often
thousands of kilometers, to the National Microbiology
Laboratory in Winnipeg, Manitoba, for final diagnosis (by
RT-PCR). Though the sensitivity and specificity of
TaqMan RT-PCR assay are excellent, the centralization of
testing and the multiple steps necessary to extract bird tis-
sues from carcasses, purify RNA, and screen samples for
WNV genome presented major logistical, biosafety,
reporting, and financial challenges. Komar et al. (2,3)
demonstrated that WNV is present in high titer in oral and
cloacal cavities of experimentally infected birds.
Recently, a rapid antigen-capture wicking assay (VecTest,
Medical Analysis Systems, Camarillo, CA) has become
commercially available (4,5). Its use for screening swabs
from the cloacal or oral cavities of dead birds has yet to be
evaluated under field conditions.
The ultimate goal of this study was to determine
whether the VecTest assay could serve as a suitable alter-
native testing procedure for WNV dead bird surveillance.
This goal was achieved by quantifying the sensitivity and
specificity of this antigen-capture assay to detect WNV in
corvids collected as part of routine dead bird surveillance
programs in Manitoba and Ontario. The effect of storage
conditions and duration of storage of swabs in grinding
solution on the sensitivity of the assay and viability of
virus was also assessed.
Materials and Methods
Corvids collected as part of the WNV dead bird surveil-
lance programs in Manitoba and Ontario, Canada, in 2001
and 2002 were used. Laboratories in each province
received dead birds, collected oropharyngeal or cloacal
swabs or tissues, performed the antigen-capture assay, and
shipped tissues or swabs to the National Microbiology
Laboratory for confirmatory testing. In both laboratories,
only birds lacking signs of obvious decay or decomposi-
tion were included for testing. Birds typically were
shipped to the laboratories via courier. During submission,
most animals were held within insulated coolers contain-
ing freezer packs. If specimens could not be shipped on the
date of collection, most were held at 4°C. On rare occa-
sions, birds were frozen at –20°C by submitters before
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However, most specimens were held at approximately 4°C
for 1 to 4 days before processing. 
Ontario/Nunavut Canadian Cooperative 
Wildlife Health Center 
Thirty-one American Crows (Corvus brachyrhynchos)
and 28 Blue Jays (Cyanocitta cristata), collected from
June to December in 2001 and held at –20°C were tested
in March and April 2002. Swabs were taken from the
oropharyngeal cavity and cloaca of each bird. In 2002,
testing was restricted to crows (n = 222) from which only
oropharyngeal swabs were collected and tested by VecTest.
Polyester swabs (VWR CanLab, Mississauga, Ontario)
were applied to the oropharyngeal cavity and the cloaca.
Swabs were placed in microcentrifuge tubes containing
1 mLof BA-1 diluent (similar to that described by Nasci et
al. [4]). The antigen-capture assay was carried out accord-
ing to the manufacturer’s instructions except that the
aliquot of swab eluate was 125 µL, not 250 µL. To confirm
the infection status of birds, approximately 25-mg pieces
of brain and kidney from each bird were pooled in micro-
centrifuge tubes and stored at –80°C before shipment to
the National Microbiology Laboratory. At that laboratory,
1 mL of BA-1 diluent and a tungsten bead (QIAGEN, Inc.
[Canada], Mississauga, Ontario) were added to each tube,
and tissues were homogenized on a Retsech Mixer mill
(QIAGEN). After centrifugation, RNA was extracted from
150- to 200-µL aliquots of supernatant.
Veterinary Services Branch, Winnipeg, Manitoba 
Beginning in mid-August, 2002, a total of 109
American Crows, 31 Blue Jays, 6 Common Ravens
(Corvus corax), and 4 Black-billed Magpies (Pica pica)
were examined. Two cloacal swabs (one each from a
Common Raven and an American Crow) and one oropha-
ryngeal swab from a Blue Jay were not taken; hence swabs
from both sites were available for a total of 147 birds.
Specimens were collected by the procedures described
above. However, after the 125-µL aliquots of swab eluate
were removed, the remainder of the sample was frozen at
–80°C and shipped to the National Microbiology
Laboratory for confirmatory RT-PCR testing. Tissues were
removed and tested for WNV by using RT-PCR on 42 (29
crows, 9 Blue Jays, 3 Common Ravens, and 1 magpie) of
the 150 birds.
In both laboratories, swabs were tested for WNV with
the VecTest assay (WNV/St. Louis encephalitis antigen
panel), as described by Nasci et al. (4), with the following
modifications. Swabs were incubated at 37°C for 30 min
and shaken intermittently; if debris was present, tubes
were centrifuged for 5 min at 4,000 rpm. Aliquots of 125
µL of the manufacturer’s grinding solution and of each
swab sample were mixed in a microcentrifuge tube. This
mixture was centrifuged by using a Vortex mixer (VWR
International, Mississauga, Ontario), and test strips were
inserted into the supernatant fluid for 15 min, then
removed and examined. During this study, two and five
different persons from the Manitoba and Ontario laborato-
ries, respectively, interpreted or read the test strips. As
illustrated by Nasci et al. (4), presence of WNV was con-
firmed by the formation of a reddish purple line on the test
strip, corresponding to the WNV-positive location and the
development of a test control line. 
Real-time TaqMan RT-PCR assays to detect WN viral
RNA, as described by Lanciotti et al. (1), were conducted
on all swabs and representative tissue samples from
Manitoba and all tissue samples from Ontario. Briefly,
RNAwas extracted from 150 µLto 200 µLof swab eluates
or tissue homogenates by using QIAamp viral RNA kits
(QIAGEN). A final volume of 70 µL of eluted RNA was
stored at –80°C until used. Five microliters of RNA was
combined with the appropriate primers and probes in
buffer with the TaqMan RT-PCR ready-mix kit (PE
Applied Biosystems, Foster City, CA). Samples were sub-
jected to 40 amplification cycles in an ABI Prism 7700
Sequence Detection System instrument (PE Applied
Biosystems), according to the manufacturer’s protocol for
TaqMan RT-PCR cycling conditions. All samples were
screened with primers and probe specific to the 3′ NTR,
and positive extracts were confirmed by reamplification
with the ENVprimers and probe (1). Swabs or tissues were
considered positive only if positive results were obtained
with both primer and probe sets. Sensitivity and specifici-
ty of the antigen-capture assay applied to oropharyngeal
and cloacal swabs from corvids were calculated by using
the results of TaqMan RT-PCR assays on swab or tissue
samples as the “true” outcome (6). 
To establish how storage conditions and duration of
storage affected the sensitivity of the antigen-capture
assay, cultures of Egypt 101 strain of WNV (approximate-
ly 4 x107 PFU/mL) were serially diluted to 4 X 104
PFU/mL in BA-1 diluent. Polyester swabs were then
dipped into each virus solution, placed into 1 mL of man-
ufacturer’s grinding solution, and held at –20°C, 4°C, or
room temperature (approximately 18°C). The test strips
were applied to aliquots of each solution 0, 3, 5, 7, 10, and
14 days later, as described previously. To assess virus via-
bility in grinding solution, 50 µL of each tested grinding
solution and virus dilution was placed into 450 µL of BA-
1 diluent, and aliquots of 200 µL of this mixture were
added to Vero cells reared on standard nutrient medium
(i.e., Dulbecco’s modified Eagle medium and 10% fetal
bovine serum [FBS]) at 37°C and 5% CO2. After a 1-h
adsorption, 2 mL of nutrient medium (same as above but
5% FBS) was added to tissue culture wells, which were
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BA-1 as above) and negative (media only) controls were
maintained under the same conditions, and cells in culture
were observed daily for cytopathic effect (CPE). Cells
from positive controls and the highest concentration of
virus used (i.e., 4 X 107 PFU/mL) in grinding solution for
each temperature and sampling date were acetone fixed,
exposed to WNV-specific antibodies (produced in rabbits
and supplied by H. Weingartl, Canadian Food Inspection
Agency, Winnipeg, Manitoba) and conjugated goat anti-
rabbit immunoglobulin (Ig) G (Kirkegaard & Perry,
Gaithersburg, MD) and assessed for fluorescence under a
UV microscope.
Results and Discussion
The sensitivity and specificity of the VecTest assay for
detecting WNV in oropharyngeal and cloacal swabs are
presented in the Table. Data from Ontario reflect the sensi-
tivity and specificity of this antigen-capture assay by using
swab eluates in relation to the infection status (TaqMan
RT-PCR on kidney and brain) of corvids. In contrast, with
the exception of 42 birds in which tissue samples were
used to establish WNV infection status, the Manitoba
results evaluate the sensitivity and specificity of the anti-
gen-capture assay by using swab eluates in relation to the
detection of virus in the same sample by TaqMan RT-PCR.
Hence, the results obtained in the two laboratories are not
directly comparable. 
Data from the Ontario birds from 2001 need to be inter-
preted with caution since sample size was small and the
birds were frozen for up to 10 months. However, cloacal
swabs appeared to be less sensitive than oropharyngeal
swabs in detecting an infected bird. The sensitivity and
specificity of the antigen-capture assay, when oropharyn-
geal swabs from crows collected in 2002 were used, were
83.3% and 95.8%, respectively, indicating that this assay is
acceptable for use as a field detection test in a WNV sur-
veillance program. The advantages of this assay compen-
sate for lower sensitivity only in areas where infected
crows are relatively common.
The Manitoba data also indicate that this antigen-cap-
ture assay is sufficiently sensitive and specific to detect
WNV in oropharyngeal and cloacal swabs from crows
when compared to RT-PCR results. Sixty-two of 109
crows were positive by RT-PCR on either oropharyngeal
or cloacal swab, although the number of birds that would
have been positive using tissues was not determined. All
but three birds positive on oropharyngeal swabs were also
positive on cloacal swabs. Small sample sizes and the rel-
atively small number of positive samples on RT-PCR make
evaluation of the utility of this antigen-capture assay on
Blue Jays, Common Ravens, and magpies difficult. In gen-
eral, the test’s specificity seems superior to its sensitivity
(Table). Further evaluation is necessary before there can be
confidence in this assay as a means of detecting WNV in
these species. 
In Manitoba, the VecTest assay was not evaluated
against RT-PCR on tissue for all birds, and thus the sensi-
tivity and specificity cannot be related to the true infection
status of each bird. However, indirect evidence suggests
that the Manitoba antigen-capture results approximate
those that would have be obtained had RT-PCR on tissues
been used in the comparison. On the 29 Manitoba crows in
which tissues were used to establish infection status by RT-
PCR, the sensitivity and specificity (i.e., 83.3% and 94.1%,
respectively) of the antigen-capture assay on oropharyn-
geal swabs were comparable to those from Ontario.
Likewise, the data from Manitoba are similar to the data on
sensitivity and specificity of the antigen-capture assay on
swab eluates from crows in Ontario and compatible with
the high prevalence or titers of virus in oropharyngeal or
cloacal samples described by Komar et al. (2,3). 
The “false-negative” VecTest samples had higher mean
cycle threshold (CT) values (i.e., CT values are a measure
of the overall virus titer in samples; higher CT values indi-
cate lower viral loads) for both primer and probe sets (i.e.,
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Table. Sensitivity and specificity of the VecTest assay to detect West Nile virus (WNV) in oropharyngeal and cloacal swabs collected 
from corvids in Ontario and Manitoba 
Oropharyngeal swabs  Cloacal swabs 
Species tested (y)  N  Sensitivity (%)  Specificity (%)  Sensitivity (%)  Specificity (%) 
Ontario 
American Crows (2001)  33  92.8  79  58.3  94.7 
Blue Jays (2001)  28  60  100  40  100 
American Crows (2002)  222  83.3  95.8  ND
a  ND 
Manitoba 
American Crows  109
b  83.9  93.6  83.1  97.9 
Blue Jays  31
c  71.4  100  57.1  100 
Common Ravens  6
b  100  100  100  0 
Black-billed Magpies  4  0  100  66.7  100 
aND, not done. 
 
bCloacal swabs were not available from one bird in each of these groups of birds. 
cAn oropharyngeal swab was not taken from one of the Blue Jays. 26.1·± 4.5, generic; ± 26.0·± 4.9, envelope) compared to
bona fide positives (i.e., 21.·0 ± 3.4, generic; 19.·7 ± 3.7,
envelope). This observation suggests that the viral titers in
the false-negative samples were below the threshold for
consistent detection when the antigen-capture format was
used. Similar but lower levels of sensitivity have been
reported for this antigen-capture assay when it has been
used to detect WNV in field-collected mosquitoes (4).
Regardless of the storage conditions of swab samples,
VecTest strips always detected WNV at viral concentra-
tions >4 X 106 PFU/mL but never at titers of 4 x 104
PFU/mL. The VecTest assay detected WNV at 4 X 105
PFU/mL when the grinding solutions were held at any of
the three temperatures for up to 7 days; thereafter WNV
was only consistently detected at 4 X 105 PFU/mL when
solutions were held at –20°C. Grinding solution appears to
inactivate WNV. None of the tissue cultures inoculated
with grinding solution containing WNV had evidence of
CPE or positive indirect fluorescent-antibody assay
results, whereas all of the positive controls did. Based on
these results, swabs can be placed in grinding solution for
up to 7 days before the test strips are applied and held from
–20°C to 18°C, without loss of sensitivity. As noted by
Nasci et al. (4), once in the grinding solution, the titer of
WNV is substantially reduced, as would be any potential
biological hazard associated with handling or shipping the
swab samples.
In noncorvid species the VecTest assay also has low
sensitivity when compared with immunohistochemistry to
detect viral antigen in fixed tissue and RT-PCR on frozen
tissue. The sensitivity of this antigen-capture assay was
46.7% for oropharyngeal swabs taken from 27 different
raptors (of various species) in Ontario during 2002 (G.D.
Campbell, Ontario Veterinary College, ON, pers. comm.).
This obviates the use of this assay as a reliable screening
test for WNV infection in rehabilitation centers, veterinary
clinics, zoos, animal disease diagnostic laboratories, and
other settings where potential exposure to a biocontain-
ment level 3 agent is of concern. 
The advantages of this antigen-capture assay over con-
ventional molecular-based diagnostic procedures such as
real-time TaqMan RT-PCR include simplicity of proce-
dures, no requirement for expensive and technically
demanding instruments, and much shorter turn-around
times for testing (i.e., results are available in 15 min). In
addition, testing swabs rather than tissues eliminates the
need to dissect submitted birds, thus decreasing the pro-
cessing time and cost of testing and the risk for lacerations
to laboratory workers (7). 
The greatest limitation to the use of this system in
WNV surveillance programs is the potential loss of infor-
mation on early season WNV activity. This loss could
result from the lower sensitivity of the antigen-capture
assay compared to the real-time RT-PCR TaqMan assay.
However, the loss of temporal sensitivity likely would be
offset somewhat by the rapid turn-around times possible
with the antigen-capture format. In addition, in our experi-
ence, the VecTest assay does not appear to work as effec-
tively in noncorvid (or all corvid) species. Thus, its useful-
ness would be greatly diminished in jurisdictions that test
all avian species as part of their WNV surveillance pro-
grams. The poorer performance of the VecTest assay in
noncorvids may be related to species-specific differences
(and variability) in virus titers in excretions and secretions
at the time of death (3). The VecTest assay will likely
replace TaqMan RT-PCR assays as the front-line diagnos-
tic test for future WNV dead bird surveillance programs in
Canada. When this antigen-capture assay is used, only
index cases of WNV infection in dead birds detected in a
given jurisdiction such as a health unit or municipality
need to be confirmed with RT-PCR assays before public
notification of virus activity. This procedure would com-
pensate for the slightly lower specificity of the antigen-
capture assay and should result in markedly decreased
workloads for laboratories using molecular diagnostic pro-
cedures. VecTest positives obtained thereafter need not be
confirmed by an alternative assay since the impact of false
positives in a jurisdiction with previously confirmed virus
activity should be negligible. 
Acknowledgments
We thank Kirti Dave for providing technical advice on the
use of the VecTest assay; Kelly Nichol for providing assistance at
the laboratory in Guelph; and Heather White for her help in
preparing the manuscript.
Dr. Lindsay is a research scientist at the National
Microbiology Laboratory of Health Canada in Winnipeg,
Manitoba. His research interests focus primarily on vector-borne
zoonotic diseases.
References
1. Lanciotti RS, Kerst AJ, Nasci RS, Godsey MS, Mitchell CJ, Savage
HM, et al. Rapid detection of West Nile virus from human clinical
specimens, field collected mosquitoes and avian samples by a
TaqManRT-PCR assay. J Clin Microbiol 2000;38:4066–71. 
2. Komar N, Lanciotti R, Bowen R, Langevin S, Bunning M. Detection
of West Nile virus in oral and cloacal swabs collected from bird car-
casses. Emerg Infect Dis 2002;8:741–2.
3. Komar N, Langevin S, Hinten S, Nemeth N, Edwards E, Hettler D, et
al. Experimental infection of North American birds with the New
York 1999 strain of West Nile virus. Emerg Infect Dis
2003;9:311–22. 
4. Nasci RS, Gottfried KL, Burkhalter KI, Kulasekera VL, Lambert AJ,
Lanciotti RS, et al. Comparison of Vero cell plaque assay, TaqMan
reverse transcriptase polymerase chain reaction RNA assay, and
VecTest antigen assay for detection of West Nile virus in field-collect-
ed mosquitoes. J Am Mosq Control Assoc 2002;18:294–300.
Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 9, No. 11, November 2003 1409
RESEARCH1410 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 9, No. 11, November 2003
RESEARCH
5. Ryan J, Dave K, Emmerich E, Fernandez B, Turell M, Johnson J, et
al. Wicking assays for the rapid detection of West Nile and St. Louis
encephalitis viral antigens in mosquitoes (Diptera: Culicidae). J Med
Entomol 2003;40:95–9. 
6. Martin SW, Meek AH, Willeberg P. Veterinary epidemiology. Ames
(IA): Iowa State University Press; 1987. p. 343.
7. Campbell G, Lanciotti R, Bernard B. Laboratory-acquired West Nile
virus infections—United States, 2002. MMWR Morb Mortal Wkly
Rep 2002;51:1133–5.
Address for correspondence: Robbin Lindsay, 1015 Arlington Street,
Winnipeg, Manitoba, Canada R3E 3R2; fax: (204) 789-2082; email:
robbin_lindsay@hc-sc.gc.ca
Search p past i issues o of E EID a at w www.cdc.gov/eid